Laura Patrucco, Patient Affairs and Advocacy Lead at PRINEOS, shared a post on LinkedIn:
“Oncology In The GCP R3 Era.
About clinical trials in oncology. I share a moment of punctual training. GCP R3 opens a new season for clinical research: more vision, more shared responsibility, more quality in processes.
In cancer centers, this evolution takes shape thanks to dedicated figures. Each with a key role in transforming studies into real value for patients. A meeting to read this change together and grow research where it really is born.
It is always useful and formative to listen to the insiders: Rossana Berardi, Massimo Di Maio, Francesca Laudato, Gennaro Daniele, Marco Bellero
On the side of participatory oncology (and not only).”
Other articles featuring Massimo Di Maio on OncoDaily.
